Pathophysiology of breast cancer
Posted by
aline
on 25 May 2022
The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization
Lucie Coillard, Frederic Guaddachi, Maëlle Ralu, Eva Brabencova, Christian Garbar, Armand Bensussan, [...]
Read morePosted by
aline
on 25 October 2021
Development of extracellular vesicle-based medicinal products: a position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France
Amanda K. A Silva, Marie Morille, Max Piffoux, Surendar Arumugam, Phlippe Mauduit, Jérôme Larghero, Arnaud [...]
Read morePosted by
supportmlcom
on 30 September 2020
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
Campedel L, Blanc-Durand P, Bin Asker A, Lehmann-Che J, Cuvier C, De Bazelaire C, Teixeira L, Becourt S, [...]
Read morePosted by
supportmlcom
on 30 August 2020
Oncogenic TRIM37 links chemoresistance and metastatic fate in triple-negative breast cancer
Przanowski, P., Lou, S., Tihagam, R., Mondal, T., Conlan, C., Shivange, G., Saltani, I., Singh, C., Xing, [...]
Read morePosted by
supportmlcom
on 30 June 2020
Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination
Cardoso Bueno de Camargo L, Guaddachi F, Bergerat D, Ourari N, Coillard L, Parietti V, Le Bras M, [...]
Read morePosted by
supportmlcom
on 28 February 2020
Multiple Roles of the Interleukin IL-17 Members in Breast Cancer and Beyond
Stephane Potteaux, Jacqueline Lehmann-Che, Armand Bensussan, Richard Le Naour, Yacine Merrouche Nature: J [...]
Read morePosted by
supportmlcom
on 31 July 2014
Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer
Groheux D, Hindié E, Giacchetti S, Hamy AS, Berger F, Merlet P, de Roquancourt A, de Cremoux P, Marty M, [...]
Read morePosted by
supportmlcom
on 11 May 2013
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, Leman-Detours S, de Roquancourt [...]
Read morePosted by
supportmlcom
on 18 October 2012
Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor
Germann S, Gratadou L, Zonta E, Dardenne E, Gaudineau B, Fougère M, Samaan S, Dutertre M, Jauliac S, [...]
Read morePosted by
supportmlcom
on 1 October 2012
Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion
Gaudineau B, Fougère M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S Nature: J Cell Sci. 2012 Oct [...]
Read more